» Call to Halt Overprescription of Medications to Elderly Patients

Call to Halt Overprescription of Medications to Elderly Patients

Moorestown, NJ (Law Firm Newswire) November 16, 2012 - During a press conference at the state Capitol, Connecticut Senator Richard Blumenthal announced his intent to halt the over-prescription of off-label antipsychotic drugs to nursing home patients.

Medical advocates and elderly care advocates also announced the formation of a Connecticut-based coalition made up of nursing home groups and public health employees. Their aim is to reduce the amount of antipsychotics prescribed to elderly patients by 15 percent, calling it "chemical restraint."

Sen. Blumenthal and the coalition of advocates, the Partnership to Improve Dementia Care in Nursing Homes, have stated that the extensive dispensing of antipsychotic medications to dementia patients, residing in long-term care facilities and nursing homes, is a form of elder abuse, no less offensive than using physical restraints. The medications in question include Olanzapine, Risperidone and Quetiapine.

Qualidigm, a Medicare quality improvement organization based in Connecticut, sponsors the coalition and Senator Bluemnthal's bill, which suggests alternative techniques for patient care, including touch therapy, music and comforting routines.

"While caring for elderly patients with dementia can bring extra challenges, we applaud the health care system taking steps to use less restrictive approaches to managing their care," stated New Jersey elder law attorney Thomas D. Begley, Jr.

The bill would require the consent from family members prior to use, and would require educational programs for prescribers and dispensing nursing home staff, as well as regular reporting on facility usage of antipsychotic drugs.
According to Blumenthal and the Partnership to Improve Dementia Care in Nursing Homes, the use of these medications for elderly dementia patients has not been approved by the FDA and can cause unresponsiveness, excessive sedation and can increase health risks such as stroke.

While the national average for prescribing these off-label antipsychotic drugs is 23.9 percent, Connecticut nursing homes currently prescribe these between 25 percent and 65 percent of the time. A report released last year by the Inspector General stated that 83 percent of nursing home care Medicare claims were for off-label conditions which included the prescribing of antipsychotic drugs.

To learn more about Begley Law Group call 1.800.533.7227 or visit www.begleylawgroup.com.

Begley Law Group, P.C.
509 S. Lenola Road, Building 7
Moorestown, NJ 08057
Tel: 800.533.7227


  • THE FUTURE OF THE LEGAL PROFESSION
    by Thomas D. Begley, Jr., CELA ABA Commission The American Bar Association has appointed a Commission on the future legal services. Legal services are expensive and are beyond the reach of many poor and even middle class individuals. Technology is becoming a game-changer and non-legal entities are engaged in providing legal services. The ABA Commission is holding a series of grassroots meetings to gather information and propose new approaches for the delivery of legal services. The Commission will look at data regarding what percentage of a lawyer’s time is actually spent practicing law as opposed to administrative, marketing, fundraising, etc. [...]
  • PERSONAL INJURY SETTLEMENTS: HOUSING FOR PLAINTIFFS WITH DISABILITIES
    by Thomas D. Begley, Jr., CELA Introduction Housing for an individual with disabilities is a major concern. The purchase of a residence is a very important decision involving a number of factors. This is particularly true where the individual is receiving means-tested public benefits such as Supplemental Security Income (SSI) and Medicaid. If there is a special needs trust involved, the SSI and State Medicaid Regulations must be carefully considered. Selecting the Right Home Often, a home must be made handicap accessible. In selecting a home, care must be taken to ensure that the home can be adapted for the [...]
  • YOU HAVE JUST BEEN DIAGNOSED WITH EARLY ALZHEIMER’S: NOW WHAT?
    by Thomas D. Begley, Jr., CELA Background on Alzheimer’s According to the American Alzheimer’s Association, Alzheimer’s disease is a progressive brain disorder that damages and eventually destroys brain cells, leading to memory loss and changes in thinking and other brain functions. It usually develops slowly and gradually gets worse as brain function declines and brain cells eventually wither and die. Ultimately, Alzheimer’s is fatal and currently, there is no cure. An estimated 5.3 million Americans of all ages have Alzheimer’s disease in 2015. Thirty-six percent are age 85 or older, 43% are between 75 and 84, 16% are between 65 [...]

See other news sources publishing this article. BETA | Tags: , , , , , , , , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required